In this article, we will discuss the 10 Most Promising Mid-Cap Stocks to Buy According to Analysts.
On June 9, Liz Ann Sonders, Charles Schwab, joined ‘Closing Bell’ on CNBC to discuss the recent market movements, suggesting that the recent sell-off helped alleviate some of the market’s overbought characteristics, which she views as a healthy development. She emphasized that the current rotational nature of the market is likely to persist and that investors must look beneath the surface of the indexes. Sonders views this ongoing rotation itself as a momentum trade that is not going away soon.
Regarding the impact of the upcoming massive IPO, Sonders agreed with market observers like Ed Yardeni that the anticipation of these large offerings has likely contributed to recent volatility in chip stocks. She suggested that the scarcity premium of existing stocks may be diluted by the size of these new offerings, even if their float is relatively low, which has pulled capital away from other names. Despite this, she cautioned against assuming that today’s rebound is an indictment of the idea that investors will rotate out of the tech trade. Saunders clarified that when she referred to the tech trade, she used a lowercase “t,” as she believes that the current build-out of AI and tech infrastructure extends well beyond the large-cap technology sector in the S&P 500. She pointed to the Russell 2000 handily outperforming the S&P 500 and noted that there is a broader participation in this infrastructure build-out that benefits more than just large-cap tech.
Our Methodology
We used screeners to identify promising stocks with market caps between $2 billion and $10 billion and an average upside potential of at least 30%. We limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among elite hedge funds and are ranked in ascending order of their upside potential.
Note: All data was sourced on June 9.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).
10 Most Promising Mid-Cap Stocks to Buy According to Analysts
10. Stantec Inc. (NYSE:STN)
Average Upside Potential: 40.85%
Stantec Inc. (NYSE:STN) is one of the most promising mid-cap stocks to buy according to analysts. On May 26, Stantec, in a joint venture with Jacobs Solutions (NYSE:J), announced it has been selected to deliver Greater Western Water’s five-year infrastructure planning and delivery program in Melbourne, Australia. The initiative focuses on planning and delivering critical water and sewer infrastructure to support long-term regional growth and resilience.
The program will address rapidly increasing demand driven by population growth in Melbourne’s western region, which is expected to more than double by 2050. The joint venture will provide end-to-end engineering and advisory services, including system design, treatment plant development, water resource assessments, and environmental analysis, as well as construction support and standards development.
Stantec Inc. (NYSE:STN) and Jacobs emphasized that the collaboration is designed to improve infrastructure reliability and sustainability while adapting to climate and population pressures. The program will also include social procurement initiatives, partnerships with Indigenous-owned businesses, and local workforce development to support broader community and economic benefits.
Stantec Inc. (NYSE:STN) provides engineering, architecture, environmental consulting, and design services across a wide range of sectors, including transportation, energy, buildings, and infrastructure. Stantec has developed a particularly strong presence in water infrastructure, supporting clients with planning, design, and program management solutions for drinking water, wastewater, flood control, and water-resource management projects around the world.
9. AECOM (NYSE:ACM)
Average Upside Potential: 41.67%
AECOM (NYSE:ACM) is one of the most promising mid-cap stocks to buy according to analysts. On June 8, AECOM announced it had been awarded a nationwide contract by the US Department of Homeland Security to continue providing architecture and engineering services for critical infrastructure modernization across the US and its territories.
The contract covers mission-critical upgrades and renovations for government facilities in all 50 states, as well as Puerto Rico, Guam, and the US Virgin Islands. AECOM’s scope includes facility design, site assessments, environmental services, planning studies, and design-build documentation across a wide range of infrastructure types, including secure, aviation, waterfront, and residential facilities.
The program also supports major initiatives such as the US Coast Guard’s multi-billion-dollar shoreline infrastructure recapitalization under its Force Design 2028 framework. AECOM (NYSE:ACM) emphasized that the award extends its long-standing partnership with DHS components and reinforces its role in delivering large-scale, security-focused infrastructure modernization projects.
AECOM (NYSE:ACM) delivers expert infrastructure consulting services to commercial and government organizations. Its services portfolio includes advising and consultation, engineering solutions, construction, and management services. It provides these services to various segments, including transportation, water, energy, and more. It is also involved in developing and investing in real estate ventures.
8. The Ensign Group Inc. (NASDAQ:ENSG)
Average Upside Potential: 43.00%
The Ensign Group Inc. (NASDAQ:ENSG) is one of the most promising mid-cap stocks to buy according to analysts. On June 2, Ensign announced the acquisition of real estate and operations for Woodland Health and Rehabilitation, a 62-bed skilled nursing facility in Mount Pleasant, Iowa. The transaction was completed through Ensign-affiliated entities, with the real estate acquired by its captive REIT, Standard Bearer Healthcare REIT.
The facility will be operated by an Ensign-affiliated tenant, further expanding the company’s skilled nursing and rehabilitative care portfolio. Leadership highlighted the acquisition as part of its continued growth in the Midwest and its broader strategy of expanding both healthcare operations and owned real estate assets.
The Ensign Group Inc. (NASDAQ:ENSG) also noted additional concurrent acquisitions and confirmed that it now operates a large and expanding network of healthcare facilities across multiple US states. The company emphasized its ongoing focus on acquiring and leasing skilled nursing and senior living properties, including both stable and underperforming operations, as part of its long-term growth strategy.
The Ensign Group Inc. (NASDAQ:ENSG) is a senior care company that operates skilled nursing facilities, rehabilitation therapy, and senior living communities. Focused on high-quality clinical care, Ensign adapts to changing healthcare reimbursement models to serve the diverse needs of aging populations.
7. MP Materials Corp. (NYSE:MP)
Average Upside Potential: 48.25%
MP Materials Corp. (NYSE:MP) is one of the most promising mid-cap stocks to buy according to analysts. On May 7, MP Materials reported its Q1 2026 financial and operational results, highlighting record production and sales of neodymium-praseodymium/NdPr and continued growth across its rare earth operations. The company generated $132.9 million in consolidated revenue and PPA income during the quarter.
Operationally, MP Materials achieved record NdPr output of 917 metric tons and record NdPr sales of 1,006 metric tons, alongside increased rare earth oxide production. The company also reported solid adjusted EBITDA performance across its materials and magnetics segments, reflecting improving scale and efficiency in its vertically integrated rare earth supply chain.
During the quarter, MP Materials Corp. (NYSE:MP) advanced its long-term expansion strategy by breaking ground on its “10X” magnetics facility and continuing development work at its Mountain Pass site. Management emphasized that these initiatives support the company’s goal of strengthening domestic rare earth processing and magnet production capacity in the US.
MP Materials Corp. (NYSE:MP) is the leading American producer of rare earth materials, focused on restoring the full supply chain to the US by mining, refining, and manufacturing high-strength neodymium-iron-boron (NdFeB) magnets. It supplies critical materials for electric vehicles, defense systems, robotics, and clean energy technologies.
6. Jack Henry & Associates Inc. (NASDAQ:JKHY)
Average Upside Potential: 50.77%
Jack Henry & Associates Inc. (NASDAQ:JKHY) is one of the most promising mid-cap stocks to buy according to analysts. On May 12, Jack Henry & Associates announced that its Board of Directors has increased the company’s stock repurchase authorization by 5 million shares, expanding the total remaining authorization to 6.4 million shares. The company noted that it has already repurchased just over 2 million shares in fiscal year 2026.
The expanded buyback program builds on a long-standing authorization structure that has been adjusted multiple times since its original approval in 2002. The company stated that repurchases will be funded through available cash reserves or short-term borrowing and executed in line with regulatory and exchange requirements, without fixed price targets or timelines.
Management emphasized that the decision reflects confidence in the company’s cash flow strength and ongoing operational performance, even while continuing investments in technology and product innovation. The repurchase program is intended to support long-term shareholder value creation.
Jack Henry & Associates Inc. (NASDAQ:JKHY) provides technology solutions and payment processing services for banks and credit unions, enabling secure, efficient financial operations and digital banking experiences.
5. Viasat Inc. (NASDAQ:VSAT)
Average Upside Potential: 51.70%
Viasat Inc. (NASDAQ:VSAT) is one of the most promising mid-cap stocks to buy according to analysts. On May 28, Viasat reported record financial performance for its Q4 and full-year 2026, including $4.9 billion in awards and a $4.1 billion backlog, alongside record revenue of $4.6 billion and adjusted EBITDA of $1.6 billion. Free cash flow improved year over year to $177 million, marking the fifth consecutive quarter of positive free cash flow generation, while net losses narrowed significantly compared to the prior year.
Operationally, the business advanced major satellite and communications programs, including successful launches of ViaSat-3 spacecraft and continued expansion of global coverage across mobility, government, and maritime markets. The company also grew its cybersecurity and government communications portfolios, securing record contract awards across encryption, defense, and satellite communications programs.
Financially, Viasat Inc. (NASDAQ:VSAT) strengthened its balance sheet by reducing debt through early redemption of senior notes and repayment of term loans, while maintaining $2.9 billion in liquidity. Strategic initiatives also included expansion of multi-orbit connectivity solutions, growth in aviation and shipping connectivity services, and the divestiture of a JV interest at an accretive valuation.
Viasat Inc. (NASDAQ:VSAT) is a global broadband and communication service provider that delivers satellite-based broadband services, narrowband communications, secure networking systems, and cybersecurity solutions. The company has two segments: Communication Services and Defense & Advanced Technologies. It also develops wireless products, terminals, and space system solutions.
4. Cytokinetics (NASDAQ:CYTK)
Average Upside Potential: 51.94%
Cytokinetics (NASDAQ:CYTK) is one of the most promising mid-cap stocks to buy according to analysts. On June 1, Cytokinetics announced the first commercial European launch of MYQORZO (aficamten) in Germany for the treatment of symptomatic obstructive hypertrophic cardiomyopathy/oHCM. The launch follows European Commission approval in February and builds on prior regulatory approvals in the US and China.
MYQORZO is a cardiac myosin inhibitor designed to reduce cardiac contractility and left ventricular outflow tract obstruction in patients with oHCM. Its approval was supported by Phase 3 SEQUOIA-HCM clinical trial results, which showed statistically significant improvements across exercise capacity, symptoms, hemodynamics, and quality-of-life measures compared to placebo.
Cytokinetics (NASDAQ:CYTK) stated that the German launch marks the first step in a broader European rollout strategy aimed at expanding access to the therapy across the region. The company emphasized strong clinical outcomes and regulatory validation as key drivers supporting its global commercialization of aficamten in treating hypertrophic cardiomyopathy.
Cytokinetics (NASDAQ:CYTK) is a biopharmaceutical company that discovers, develops, and commercializes muscle activators and muscle inhibitors as potential treatments for debilitating diseases. The company’s clinical-stage drug candidates include omecamtiv mecarbil, CK-136, reldesemtiv, aficamten, and CK-3772271.
3. AeroVironment Inc. (NASDAQ:AVAV)
Average Upside Potential: 68.55%
AeroVironment Inc. (NASDAQ:AVAV) is one of the most promising mid-cap stocks to buy according to analysts. On June 2, AeroVironment announced plans to invest $15 million to expand its advanced production capabilities in Greene County near Dayton, Ohio. The expansion includes new facilities in Beavercreek and Xenia to support pilot-scale and mid-volume production, including advanced biotechnology manufacturing and defense-related components.
The project is designed to strengthen domestic manufacturing capacity for critical defense and biotechnology programs, with close proximity to the Air Force Research Laboratory /AFRL and Wright-Patterson Air Force Base. The expanded sites will support manufacturing, integration, and testing activities aligned with national security priorities, while also enabling future scale-up into full-rate production.
The investment is expected to create around 200 new jobs and generate significant regional economic impact, supported by state and regional incentive programs. AeroVironment Inc. (NASDAQ:AVAV) emphasized that the expansion is part of a broader strategy to enhance US defense manufacturing capacity, improve supply chain resilience, and accelerate the development of advanced mission-critical technologies.
AeroVironment Inc. (NASDAQ:AVAV) designs and manufactures unmanned aerial vehicles, ground robotic systems, and loitering munitions.
2. Chewy Inc. (NYSE:CHWY)
Average Upside Potential: 96.08%
Chewy Inc. (NYSE:CHWY) is one of the most promising mid-cap stocks to buy according to analysts. On June 10, Chewy reported its FQ1 2026 financial results, highlighting continued growth in revenue and profitability. The company posted net sales of $3.36 billion, representing a 7.7% year-over-year increase, alongside improved gross margin and net income performance.
Profitability metrics strengthened during the quarter, with net income reaching $94.8 million and adjusted EBITDA rising to $253.1 million. Margins also expanded across multiple measures, reflecting improved operational efficiency and continued scaling of the company’s digital retail platform.
Management attributed the results to strong customer growth, market share gains in the pet category, and disciplined execution across its business model. The company emphasized its ongoing focus on profitable expansion, customer acquisition, and long-term shareholder value creation in a competitive consumer environment.
Chewy Inc. (NYSE:CHWY) is involved in the e-commerce business across the United States. The company provides pet supplies and medications, pet food and treats, and other pet health products. It is based in Plantation, Florida, and was incorporated in 2010.
1. BitMine Immersion Technologies Inc. (NYSE:BMNR)
Average Upside Potential: 140.74%
BitMine Immersion Technologies Inc. (NYSE:BMNR) is one of the most promising mid-cap stocks to buy according to analysts. On June 8, BitMine Immersion reported that its total crypto and cash holdings reached $9.6 billion, driven primarily by a large Ethereum/ETH treasury position. The company disclosed holdings of over 5.5 million ETH, alongside smaller Bitcoin positions, cash reserves, and additional strategic investments.
The company stated it now controls approximately 4.59% of the total ETH supply, supported by aggressive accumulation and large-scale staking operations. A significant portion of its ETH holdings is staked through its institutional staking platform, MAVAN, contributing to projected annual staking revenue and reinforcing BitMine’s position as one of the largest Ethereum treasuries globally.
BitMine Immersion Technologies Inc. (NYSE:BMNR) also highlighted broader strategic investments and infrastructure expansion in the crypto ecosystem, including staking platform development and equity “moonshot” positions. Management emphasized Ethereum’s long-term role in supporting decentralized finance and AI-driven systems, framing the company’s accumulation strategy as aligned with expected growth in blockchain adoption and network utility.
BitMine Immersion Technologies Inc. (NYSE:BMNR) is a digital asset company. It was originally focused on Bitcoin mining and hosting services, but has pivoted toward building a massive Ethereum treasury. The company has also developed infrastructure such as its MAVAN validator network, which serves as an institutional-grade Ethereum staking platform.
READ NEXT: 10 Most Undervalued Large Cap Stocks to Buy According to Analysts and 10 Most Promising Penny Stocks According to Wall Street Analysts.
Disclosure: None. None. Follow Insider Monkey on Google News.
